Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension label

Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension

Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Do not use if glued carton en flaps are open or if the tube seal is broken.

Stop use and ask doctor if condition persists for more than 3 days or worsens.

For external use only
Avoid contact with eyes.

If swallowed, get medical help or contact a Poison Control Center right away.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Temporarily relieves muscle pain and stiffness due to minor injuries, overexertion and falls. Reduces pain, swelling and discoloration from bruises.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension Manufacturers

  • Tris Pharma, Inc.
    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Laboratoires Boiron
    No Recall

    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Laboratoires Boiron

    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Laboratoires Boiron

    Apply a thin layer of Arnicare Cream to affected area and massage after minor injury. Repeat 3 times a day or as needed.

  • Par Pharmaceutical Companies Inc
    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Par Pharmaceutical Companies Inc
    No Recall

    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Par Pharmaceutical Companies Inc

    Hydrocodone Polistirex And Chlorpheniramine Polisitrex Suspension | Par Pharmaceutical Companies Inc

    It is important that hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension is measured with an accurate measuring device (see PRECAUTIONS, Information for Patients).

    A dosing cup is provided with the 4 fl. oz. (115 mL) packaged product. The dosing cup fills for a 2.5 mL and for a 5 mL dose. Instruct the patient to fill to the line for the dose that has been prescribed. Do not fill over the dose prescribed. Rinse with water after each use.

    For prescriptions where a dosing device is not provided, a pharmacist can provide an appropriate measuring device and can provide instructions for measuring the correct dose. A household teaspoon is not an accurate measuring device and could lead to overdosage.

    Each 5 mL of hydrocodone polistirex and chlorpheniramine polistirex ER oral suspension contains hydrocodone polistirex equivalent to 10 mg hydrocodone bitartrate, and chlorpheniramine polistirex equivalent to 8 mg chlorpheniramine maleate. Shake well before using. Rinse the measuring device with water after each use.

    Shake well before using.

    Adults and Children 12 Years and Older

    5 mL (1 teaspoonful) every 12 hours; do not exceed 10 mL (2 teaspoonfuls) in 24 hours.

    Children 6 to 11 Years of Age

    2.5 mL (½ teaspoonful) every 12 hours; do not exceed 5 mL (1 teaspoonful) in 24 hours.

    This medicine is contraindicated in children under 6 years of age (see CONTRAINDICATIONS).